Inmune Bio Inc. (INMB)

Market Closed

1 Sep, 20:00

NASDAQ (CM)

2. 24

-0.06

-2.6087%

After Hours

2. 30

+0.06 +2.6786%

61.15M Market Cap

- P/E Ratio

- Div Yield

205,278 Volume

-2.19 Eps

$ 2.3

Previous Close

Investors:

Day Range

2.22 2.27

Year Range

1.09 2.5

Want to track INMB and more in your Portfolio? 🎯

Inmune Bio Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Curtis Ellergodt Rothschild Investment LLC	585	$661	$1,111.5	$450.5	68.15%
NA Nizar Araji National Bank Of Canada /FI/	2,000	$2,560	$4,170	$1,610	62.89%
Point72 Asset Management LP Point72 Asset Management LP	16,577	$21,218.56	$35,972.09	$14,753.53	69.53%
Jeffery Yorg Focus Partners Advisor Solutions LLC	43,556	$118,175.14	$82,756.4	-$35,418.74	-29.97%
Bobby Adusumilli SJS Investment Consulting Inc.	9	$10.17	$15.75	$5.58	54.87%
Drew Phillips Fortitude Family Office LLC	79	$101.12	$138.25	$37.13	36.72%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	17	$21.31	$32.04	$10.73	50.35%
Kevin Kroskey True Wealth Design LLC	11	$13	$19.25	$6.25	48.08%
Christopher C. Powers Farther Finance Advisors, LLC	370	$465.8	$647.5	$181.7	39.01%
JWM JPL Wealth Management LLC JPL Wealth Management, LLC	6	$7.68	$13.02	$5.34	69.53%
Ashley Meredith Abel Hall, LLC	24,559	$31,435.52	$42,978.25	$11,542.73	36.72%
MA Marie-Andree Alain Federation des caisses Desjardins du Quebec	400	$4,124	$868	-$3,256	-78.95%
Matthew Okkerse Dauntless Investment Group LLC	100	$156	$204	$48	30.77%